Physiochemical and biological properties of modified collagen sponge from porcine skin

[1]  Ba-fang Li,et al.  Characterization of acid-soluble collagen from the skin of walleye pollock (Theragra chalcogramma) , 2008 .

[2]  A. Kishida,et al.  Physical and biological properties of collagen-phospholipid polymer hybrid gels. , 2007, Biomaterials.

[3]  A. Kerkeni,et al.  Comparative wettability study of polystyrene functionalized with different proteins , 2007 .

[4]  Shiue-Cheng Tang,et al.  EDC/NHS-mediated heparinization of small intestinal submucosa for recombinant adeno-associated virus serotype 2 binding and transduction. , 2007, Biomaterials.

[5]  C. Cao,et al.  Cytocompatibility and blood compatibility of multifunctional fibroin/collagen/heparin scaffolds. , 2007, Biomaterials.

[6]  J. Bernhagen,et al.  The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. , 2006, Biomaterials.

[7]  A A Poot,et al.  Electrospinning of collagen and elastin for tissue engineering applications. , 2006, Biomaterials.

[8]  H. Lee,et al.  Preparation of porcine small intestinal submucosa sponge and their application as a wound dressing in full-thickness skin defect of rat. , 2005, International journal of biological macromolecules.

[9]  Jia-cong Shen,et al.  Cartilage tissue engineering PLLA scaffold with surface immobilized collagen and basic fibroblast growth factor. , 2005, Biomaterials.

[10]  Y. Tabata,et al.  Type I collagen can function as a reservoir of basic fibroblast growth factor. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[11]  K. Kugiyama,et al.  Angiogenic strategy for human ischemic heart disease: Brief overview , 2004, Molecular and Cellular Biochemistry.

[12]  P. Angele,et al.  Influence of different collagen species on physico-chemical properties of crosslinked collagen matrices. , 2004, Biomaterials.

[13]  R. Coleman,et al.  Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. , 2004, The Annals of thoracic surgery.

[14]  A. Mikos,et al.  Angiogenesis with biomaterial-based drug- and cell-delivery systems , 2004, Journal of biomaterials science. Polymer edition.

[15]  W. Friess,et al.  Collagen as a carrier for on-site delivery of antibacterial drugs. , 2003, Advanced drug delivery reviews.

[16]  W. J. Wang,et al.  Crosslinked collagen/chitosan matrix for artificial livers. , 2003, Biomaterials.

[17]  A. Schor,et al.  Growth factors in the treatment of diabetic foot ulcers , 2003, The British journal of surgery.

[18]  J. Veerkamp,et al.  Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. , 2002, Journal of biomedical materials research.

[19]  Y. Tabata,et al.  Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits. , 2002, Biomaterials.

[20]  Shawn M. Sweeney,et al.  Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen* , 2002, The Journal of Biological Chemistry.

[21]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[22]  J. Saliba,et al.  Heparin in the treatment of burns: a review. , 2001, Burns : journal of the International Society for Burn Injuries.

[23]  J. Feijen,et al.  Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. , 2001, Biomaterials.

[24]  J. Feijen,et al.  Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[25]  J. Veerkamp,et al.  Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. , 2000, Biomaterials.

[26]  A A Poot,et al.  Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[27]  A. Sano,et al.  Protein release from collagen matrices. , 1998, Advanced drug delivery reviews.

[28]  J. Watanabe,et al.  Immunohistochemical localization of type II and type I collagens in articular cartilage of the femoral head of dexamethasone-treated rats , 1997, The Histochemical Journal.

[29]  Shawn M. Sweeney,et al.  Type I collagen-heparin interactions in angiogenesis , 1997 .

[30]  C. S. Chen,et al.  Pore strain behaviour of collagen-glycosaminoglycan analogues of extracellular matrix. , 1995, Biomaterials.

[31]  C. M. Ofner,et al.  The determination of epsilon-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometric method using trinitrobenzenesulfonic acid. , 1992, Analytical biochemistry.

[32]  J. Gergely,et al.  Zero-length crosslinking procedure with the use of active esters. , 1990, Analytical biochemistry.

[33]  J. Saliba,et al.  Heparin in the Treatment of Burns , 1967 .

[34]  C. Werner,et al.  Heparin intercalation into reconstituted collagen I fibrils: Impact on growth kinetics and morphology. , 2008, Biomaterials.